United Kingdom · Question · Written question
UIN 23391
Ivacaftor/tezacaftor/elexacaftor
Original
Introduced
28 June 2021
Last action
7 July 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
7 July 2021
Summary
To ask the Secretary of State for Health and Social Care, what steps are being taken to make Kaftrio available for the treatment of cystic fibrosis in the UK.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
28 June 2021
Written question
To ask the Secretary of State for Health and Social Care, what steps are being taken to make Kaftrio available for the treatment of cystic fibrosis in the UK.
Source: Commons
7 July 2021
Answer
Kaftrio is available to National Health Service patients in England in line with its licence through a four year interim access deal negotiated between NHS England and NHS Improvement and Vertex, the drug manufacturer. NHS England and NHS Improvement are ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-06-28/23391
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1341281
- uk · wq-1341281 · source updated 7 July 2021